Brian Titus - May 7, 2021 Form 4 Insider Report for Corteva, Inc. (CTVA)

Role
Vice President, Controller and Principal Accounting Officer
Signature
/s/Abigail Jarrell, by power-of-attorney
Stock symbol
CTVA
Transactions as of
May 7, 2021
Transactions value $
-$475,847
Form type
4
Date filed
5/11/2021, 05:50 PM
Next filing
Jan 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTVA Common Stock Options Exercise $350K +10.8K +56.15% $32.36 30.1K May 7, 2021 Direct F1
transaction CTVA Common Stock Options Exercise $453K +13.1K +43.46% $34.68 43.1K May 7, 2021 Direct
transaction CTVA Common Stock Options Exercise $190K +6.07K +14.08% $31.22 49.2K May 7, 2021 Direct
transaction CTVA Common Stock Sale -$1.47M -29.9K -60.87% $49.04 19.2K May 7, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTVA Non-Qualified Stock Options Options Exercise $0 -10.8K -100% $0.00* 0 May 7, 2021 Common Stock 10.8K $32.36 Direct F3
transaction CTVA Non-Qualified Stock Options Options Exercise $0 -13.1K -100% $0.00* 0 May 7, 2021 Common Stock 13.1K $34.68 Direct F3
transaction CTVA Non-Qualified Stock Options Options Exercise $0 -6.07K -33.33% $0.00 12.1K May 7, 2021 Common Stock 6.07K $31.22 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes acquisition of shares pursuant to dividend reinvestment.
F2 The price reported represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $49.01 to $49.0501, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 This option is fully vested and exercisable.
F4 6,070 options are vested and exercisable. The remaining options will vest in two equal installments on February 21, 2022 and February 21, 2023.

Remarks:

Vice President, Controller and Principal Accounting Officer